Related Experiment Video
Updated: May 19, 2026
14:45
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
Pathogenesis of Parkinson's disease.
Etienne C Hirsch1, Peter Jenner, Serge Przedborski
1Université Pierre et Marie Curie-Paris 06, Centre de Recherche de l'Institut du Cerveau et de la Moëlle Épinière, Hôpital de la Salpêtrière, Paris, France.
Summary
Parkinson's disease pathogenesis involves cell-autonomous issues like mitochondrial dysfunction and non-cell-autonomous factors such as protein misfolding and neuroinflammation. Effective treatments for Parkinson's disease may require interventions targeting multiple pathways.
Area of Science:
- Neuroscience
- Pathology
- Cell Biology
Background:
- Parkinson's disease (PD) is a prevalent adult-onset neurodegenerative disorder with largely unknown causes.
- Current understanding suggests PD pathogenesis involves both cell-autonomous and non-cell-autonomous mechanisms.
- Identifying these mechanisms is crucial for developing effective neuroprotective strategies.
Purpose of the Study:
- To elucidate the multifactorial nature of Parkinson's disease pathogenesis.
- To explore the roles of cell-autonomous and non-cell-autonomous mechanisms in neurodegeneration.
- To provide insights into potential therapeutic targets for Parkinson's disease.
Main Methods:
- Review and synthesis of existing literature on Parkinson's disease mechanisms.
- Analysis of proposed cell-autonomous pathways including mitochondrial bioenergetics and calcium homeostasis.
- Examination of non-cell-autonomous factors like protein misfolding and neuroinflammation.
Main Results:
- Cell-autonomous mechanisms implicated in PD include mitochondrial dysfunction and impaired mitochondrial turnover.
- Non-cell-autonomous mechanisms involve prion-like spread of misfolded proteins and neuroinflammatory processes.
- Neurodegeneration in Parkinson's disease results from a complex cascade of pathogenic events.
Conclusions:
- Parkinson's disease pathogenesis is multifactorial, involving a combination of cellular and extracellular mechanisms.
- Effective neuroprotective therapies for Parkinson's disease may necessitate combination drug interventions.
- Further research into these mechanisms could reveal novel therapeutic targets for Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.